Effect of Rosuvastatin on Non-Alcoholic Steatohepatitis in Patients with Metabolic Syndrome and Hypercholesterolaemia. A Preliminary Report.

Conclusions: These preliminary findings suggest that rosuvastatin could ameliorate NASH within a year of treatment in MetS patients with dyslipidaemia. PMID: 24805248 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24805248?dopt=Abstract

Source: Current Vascular Pharmacology - May 8, 2014 Category: Drugs & Pharmacology Authors: Mikhailidis DP Tags: Curr Vasc Pharmacol Source Type: research